| URL | https://www.thomasnet.com/insights/moderna-gets-17 |
| Source | thomas.net |
| Date Published | 07/05/2024 |
| Author Name | Kat de Naoum |
| Company/Division name | Moderna Inc. |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2024 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 176 |
| City reshored to: | Cambridge |
| State(s) reshored to: | MA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | bird flu vaccine |
| What domestic positive factors made reshoring more attractive? | Government Incentives |
| Government Incentive dollar amount: | DoD contract |